Key Insights

Highlights

Success Rate

63% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

21.4%

3 terminated out of 14 trials

Success Rate

62.5%

-24.0% vs benchmark

Late-Stage Pipeline

7%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

63% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (7)
P 1 (1)
P 2 (1)
P 3 (1)

Trial Status

Completed5
Unknown3
Terminated3
Active Not Recruiting1
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

62.5%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
Showing all 14 trials

Research Network

Activity Timeline